Related Experiment Video
Updated: Oct 12, 2025

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Nanomedicine for the Diagnosis and Therapy of COVID-19
Yingruo Wang1, Yuanping Hao2, Shunxin Fa3,4
1Shandong University of Science and Technology, Qingdao, China.
Insights
Nanomaterials offer promising solutions for diagnosing and treating coronavirus disease 2019 (COVID-19). This review explores their role in detection, therapy, and enhancing immune response against SARS-CoV-2.
Area of Science:
- Materials Science
- Nanotechnology
- Infectious Diseases
- Medical Diagnostics
- Therapeutics
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, poses a significant global health threat due to rapid spread and limited effective interventions.
- There is an urgent need for accessible point-of-care diagnostics and treatments to control the pandemic.
- Nanomaterials exhibit unique properties that can be leveraged for medical applications.
Purpose of the Study:
- To summarize recent advancements in the application of nanomaterials for the diagnosis of COVID-19.
- To review the therapeutic potential of nanomaterials in combating COVID-19.
- To discuss limitations, challenges, and future perspectives in nano-diagnosis and nano-therapy for COVID-19.
Main Methods:
- Review of current literature on nanomaterial applications in COVID-19 diagnosis and therapy.
- Analysis of the physicochemical properties of functional nanomaterials.
- Exploration of fabrication and chemical modification techniques for nanomaterials.
Main Results:
- Nanomaterials show potential for sensitive detection of SARS-CoV-2.
- Nanomaterials can inhibit virus-host cell interactions and enhance immune responses.
- Emerging applications include nano-based diagnostic tools and therapeutic strategies.
Conclusions:
- Nanomaterials represent a promising frontier for developing advanced diagnostic and therapeutic solutions for COVID-19.
- Further research is needed to overcome current challenges and fully realize the potential of nanomaterials in managing the pandemic.
- This review aims to guide researchers toward breakthroughs in nano-diagnosis and nano-therapy for COVID-19.
Abstract:
The coronavirus disease-2019 (COVID-19) pandemics caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading around the world due to its high infection rate, long incubation period, as well as lack of effective diagnosis and therapy or vaccines, which is tearing global health systems apart. It is an urgent demand for point-of-care diagnosis and effective treatment to prevent the spread of COVID-19. Currently, based on the rapid development of functional materials with unique physicochemical features through advanced fabrication and chemical modification, nanomaterials provide an emerging tool to detect SARS-CoV-2, inhibit the interplay in the virus and host cell interface, and enhance host immune response. In our manuscript, we summarized recent advances of nanomaterials for the diagnosis and therapy of COVID-19. The limitation, current challenges, and perspectives for the nano-diagnosis and nano-therapy of COVID-19 are proposed. The review is expected to enable researchers to understand the effect of nanomaterials for the diagnosis and therapy of COVID-19 and may catalyze breakthroughs in this area.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

